There was good concordance between SLC7A11 (which encodes xCT), NQO1, GCLC and GCLM median expression levels across tumours (Fig. 5a), providing an ‘antioxidant signature’ associated with the NRF2 transcriptional programme. The gene discussed is GCLC; the disease is neoplasm.